Protective Effects of Tongxinluo, Carvedilol and Valsartan on Microvascular Endothelial Function and Integrity after Late Reperfused AMI in Rabbits

YANG Yue-jin,ZHANG Jian,WU Yong-jian,TANG Yi-da,CHEN Xi,RUAN Ying-mao,YOU Shi-jie,LIU Kun-shen,CHEN Ji-lin,GAO Run-lin,CHEN Zai-jia

DOI: https://doi.org/10.3321/j.issn:1000-4718.2006.07.024

2006-01-01

Abstract:AIM: To compare the protective effects of tongxinluo, a Chinese medicine, and carvedilol and valsartan on myocardium microvascular endothelial function and integrity after late reperfusion of acute myocardial infarction (AMI) in rabbits. METHODS: Forty-eight rabbits were randomly assigned to the following groups: (1) sham operated rabbits; (2) ischemia-reperfusion (I-R) controls; (3) tongxinluo (1.0 g·kg~ -1·d~ -1); (4) carvedilol (5 mg·kg~ -1·d~ -1); (5) valsartan (10 mg·kg~ -1·d~ -1) and (6) ticlopidine + aspirine (30 and 20 mg·kg~ -1·d~ -1, respectively) groups. After 3 d of drug treatment, the left coronary artery in the rabbit was ligated for 2 h and loosed subsequently for another 2 h. The serum levels of nitric oxide (NO_2~-/NO_3~-) and endothelin (ET) at baseline before AMI, 2 h after both AMI and reperfusion were examined. Also, the number of circulating endothelial cells (CEC), MI size and percentage myocardium focal bleeding incidence were determined 2 h after reperfusion. RESULTS: (1) The baseline level of NO_2~-/NO_3~- was significantly higher in tongxinluo group than that in other groups (all P0.01), whereas the content of ET was not significantly different among the groups. 2 h after both AMI and reperfusion, NO_2~-/NO_3~- was significantly reduced (P0.05, P0.01) and ET was significantly increased in each group as compared with their baseline (P0.05, P0.01). Yet among the groups, NO_2~-/NO_3~- was still significantly higher and ET was significantly lower in tongxinluo-treated group than that in the other groups (P0.05, P0.01). (2) CEC number was significantly increased in I-R controls as compared with sham group (P0.01), and was significantly reduced in the tongxinluo-treated groups as compared with I-R controls (P0.05). (3) MI size was significantly reduced in the four treatment groups as compared with I-R controls (all P0.01). (4) The percentage of myocardium focal bleeding incidence was significantly lower in tongxinluo and valsartan-treated groups than that in I-R controls (P0.05, P0.01). CONCLUSION: Tongxinluo as well as valsartan effectively protects myocardium endothelial function and integrity during AMI and late reperfusion, with the effects of tongxinluo being superior.